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Polycomb repressive complex 2 
facilitates the nuclear export of the 
influenza viral genome through the 
interaction with M1
Masamitsu N. Asaka1, Atsushi Kawaguchi1,2, Yuri Sakai2, Kotaro Mori1 & Kyosuke Nagata1
The organization of nuclear domains is crucial for biological events including virus infection. Newly 
synthesized influenza viral genome forms viral ribonucleoprotein (vRNP) complexes and is exported 
from the nucleus to the cytoplasm through a CRM1-dependent pathway mediated by viral proteins M1 
and NS2. However, the spatio-temporal regulation of the progeny vRNP in the nucleus is still unclear. 
Here we found that polycomb repressive complex 2 (PRC2), which contains a methyltransferase subunit 
EZH2 and catalyzes histone H3K27me3 for the formation of facultative heterochromatin, is a positive 
factor for the virus production. Depletion of PRC2 complex showed the nuclear accumulation of vRNP 
and the reduction of M1-vRNP complex formation. We also found that PRC2 complex directly binds to 
M1, and facilitates the interaction of M1 with vRNP. In conclusion, we propose that the progeny vRNP 
could be recruited to facultative heterochromatin and assembled into the export complex mediated by 
PRC2 complex.
The genome of influenza A virus consists of eight-segmented and single-stranded RNAs of negative polarity 
(vRNA). vRNA forms viral ribonucleoprotein complexes (vRNP) with viral RNA-dependent RNA polymerases 
and nucleoprotein (NP). After the nuclear import of incoming vRNP, nuclear structures and functions are remod-
eled possibly for the replication and transcription of vRNA, and post-replicational processes1.
The nucleus is highly compartmentalized into chromosome territories and numerous distinct nuclear 
compartments such as nucleolus, promyelocytic leulemia nuclear body (PML NB), spliceosome, and so on. 
Chromatin forms either a condensed and transcriptionally inactive structure called heterochromatin or a relaxed 
and transcriptionally active structure called euchromatin. Heterochromatin is classified into two groups based on 
histone modifications. One is constitutive heterochromatin (cHC) marked by histone H3 lysine 9 trimethylation 
(H3K9me3) mediated by a variety of factors including, RIZ1, SUV39H1, SUV39H2, SETDB, and so on2. The 
other is facultative heterochromatin (fHC) marked by histone H3 lysine 27 trimethylation (H3K27me3) mediated 
by polycomb repressive complex 2 (PRC2)3 and histone H2A lysine 119 (H2AK119Ub) ubiquitination mediated 
by polycomb repressive complex 1 (PRC1)4.
After transport of incoming influenza virus vRNP into the nucleus, viral polymerases interact with cel-
lular RNA polymerase II machineries for the viral transcription at euchromatin5–8. vRNP also interacts with 
heterochromatin through the histone tails containing H3K9me3 and H3K27me39–12. However, the functional 
significance of heterochromatin localization of vRNP is unknown. After viral genome replication, newly syn-
thesized vRNA is assembled into vRNP, followed by export from the nucleus to the cytoplasm mediated by the 
CRM1-dependent pathway13–15. A current model of the nuclear export of vRNP suggests that M1 directly binds 
to vRNP16,17, and M1 is then linked to CRM1 by NS2 through its nuclear export signal (NES)15,18. It has been 
suggested that heterochromatin functions as a scaffold to form vRNP export complexes due to the localization of 
vRNP export complexes at heterochromatin19. It is also reported that M1 and NS2 are localized at PML NB with 
vRNA in cells treated with a potent CRM1 inhibitor, leptomycin B20. However, the detail of the spatio-temporal 
dynamics of the progeny vRNP in the nucleus is unclear.
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Here we found that a punctate localization pattern of EZH2, a catalytic subunit of PRC2 complex, becomes 
dispersed after influenza virus infection. vRNP was found to interact with PRC2 complex in infected cells. EZH2, 
EED, and SUZ12 are required for a minimal methyltransferase activity of PRC2 complex21,22. EED recognizes 
histone H3K27me3 to recruit PRC2 complex onto fHC to maintain the methylation level23. SUZ12 binds to EZH2 
through EED and stimulates the methyltransferase activity21. Knockdown (KD) analyses indicated that EZH2 
stimulates the vRNP export in a methyltransferase activity-independent manner. Further, we showed that PRC2 
complex facilitates the association of M1 with vRNP. Taking these findings together, we propose that PRC2 com-
plex promotes the nuclear export of vRNP by recruiting M1 onto vRNP.
Results
PRC2 complex is a positive factor for the virus production. To analyze the effect of the virus infection 
on the nuclear compartments, we carried out indirect immunofluorescence assays with either mock-infected or 
infected cells using antibodies against cellular factors related to the nuclear structures such as euchormatin, het-
erochromatin and nuclear matrix (Fig. 1a). We found that punctate foci of EZH2 becomes dispersed through the 
nucleus in response to the infection, although the function of EZH2 foci is unclear24. In contrast to the case for 
EZH2, we did not observe localization changes for other proteins. EZH2 is a catalytic subunit of PRC2 complex 
methyltransferase. It is known that PRC2 complex induces the fHC formation through the methyltransferase 
activity of histone H3K27me3 and represses cellular gene expression. To examine whether PRC2 complex is 
involved in a process of progeny virion production, we examined the effect of EZH2 KD on the virus titer. The 
expression level of EZH2 in KD cells decreased to approximately 15% of that in control cells at 72 h post trans-
fection (Fig. 1b and Supplementary Fig. 1). EZH2 KD reduced the amounts of SUZ12 due to the degradation as 
previously reported (Fig. 1c and Supplementary Fig. 2)25. The amount of infectious progeny virions produced 
from EZH2 KD cells was reduced to approximately 30% of that produced from control cells (Fig. 1d). Thus, we 
concluded that PRC2 complex stimulates the production of infectious viruses.
EZH2 and other PRC2 complex components are predominantly localized in the nucleus (Fig. 1a). We assumed 
that PRC2 complex affects the viral genome functions in the nucleus, such as the viral genome replication, viral 
transcription, and nuclear export of vRNP. Thus, we examined the amounts of vRNA and viral mRNA in EZH2 
KD cells at 6 h post infection. We found that the expression levels of vRNA and viral mRNA in EZH2 KD cells 
were unchanged compared with those in control cells (Fig. 1e). In addition, the expression levels of viral proteins 
were not affected by EZH2 KD (Fig. 1f and Supplementary Fig. 3). Therefore, it is possible that PRC2 complex is 
not involved in the replication and transcription of the viral genome.
PRC2 complex is required for the nuclear export of vRNP. Next, we examined the nuclear export 
of vRNP by fluorescent in situ hybridization (FISH) assays. In control cells, more than 90% of cells showed the 
cytoplasmic localization pattern of vRNA at 6 h post infection (Fig. 2a,b). On the other hand, approximately 43% 
of EZH2 KD cells exhibited the nuclear localization of vRNA, suggesting that PRC2 complex is required for the 
nuclear export of vRNP (Fig. 2a,b). NF-κ B is a nucleocytoplasmic shuttling protein mediated by CRM1, and 
showed the nuclear localization by inhibiting CRM126. In contrast to vRNP, NF-κ B was successfully exported 
to the cytoplasm in control and EZH2 KD cells, suggesting that EZH2 KD does not impair the CRM1 function 
(Fig. 2a). The expression levels of M1 and NS2, which are viral proteins and involved in the nuclear export of 
vRNP, were not different between control and EZH2 KD cells (Fig. 1f and Supplementary Fig. 3).
It has been reported that CRM1 and other viral proteins were recruited to heterochromatin, and hetero-
chromatin functions as a scaffold to assemble the export complex of vRNP19. Thus, it is possible that EZH2 KD 
disrupts the fHC structure, thereby inhibiting the vRNP export. Hence, we next examined whether the methyl-
transferase activity of PRC2 complex is required for the vRNP export using GSK126, a potent methyltransferase 
inhibitor of EZH227. The histone H3K27me3 level was decreased to 25% in GSK126-treated cells (Fig. 2c and 
Supplementary Fig. 4), but we found that vRNP was successfully exported to the cytoplasm in GSK126-treated 
cells at 6 h post infection (Fig. 2d,e). Thus, it is likely that the nuclear accumulation of vRNP in EZH2 KD cells is 
not due to the reduction of the histone H3K27me3 level, and the methyltransferase activity of PRC2 complex is 
not involved in the nuclear export of vRNP.
PRC2 complex interacts with vRNP-M1 complex. From the results shown in Fig. 2, it is possible that 
PRC2 complex binds to vRNP and stimulates the nuclear export of vRNP. To address this, we carried out immu-
noprecipitation assays with infected cell lysates using anti-NP antibody to detect the interaction of NP/vRNP 
with PRC2 complex. We found that not only EZH2 but also EED and SUZ12 were co-immunoprecipitated with 
vRNP (Fig. 3a and Supplementary Fig. 5). Further to examine whether these chromatin proteins interact with 
NP associated with viral RNAs, the cell lysates prepared from infected cells were subjected to immunoprecipita-
tion assays with anti-EZH2 and anti-SUZ12 antibodies, respectively. The amounts of co-precipitated viral RNAs 
were quantitatively determined by quantitative RT-PCR. The amount of vRNA co-immunoprecipitated with 
endogenous EZH2 and SUZ12 was 17.31 ± 0.57 and 10.36 ± 0.64 times more than cRNA, respectively (Fig. 3b). 
These results indicate that PRC2 complex interacts with vRNP in infected cells. Next, we carried out immuno-
precipitation assays with cell lysates prepared from infected HeLa cells expressing 3xFLAG-EZH2. We found that 
viral polymerases, NP, and M1 were co-immunoprecipitated with 3xFLAG-EZH2, but NS2 was not (Fig. 3c and 
Supplementary Fig. 6).
PRC2 complex is required for the interaction between M1 and vRNP. vRNP is exported from the 
nucleus to the cytoplasm mediated by the CRM1-dependent pathway through the interaction of M1 and NS2 
with vRNP. To test whether PRC2 complex regulates the association of M1 with vRNP, we carried out proxim-
ity ligation assays (PLA) using rabbit anti-M1 and mouse anti-NP (mAb61A5) antibodies. It is reported that 
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Figure 1. PRC2 complex is involved in the viral life cycle. (a) Remodeling of nuclear compartments by 
influenza virus infection. At 6 h post infection, mock-infected (upper panel) or infected (lower panel) HeLa cells 
were subjected to indirect immunofluorescence assays with anti-EZH2, anti-Pol II, anti-HP1β , anti-RAD21, 
anti-HDAC1, anti-Brg1, anti-Topo II, and anti-CTCF antibodies, respectively (green). Nuclei were counter-
stained with DAPI (blue). Punctate foci of EZH2 are indicated by arrowheads.  (b) Knockdown efficiency of 
EZH2. HeLa cells were transfected with either control siRNA or siRNA against EZH2. At 60 h post transfection, 
1 × 105 cells (lane 1), 5 × 104 cells (lane 2), 2.5 × 104 cells (lane 3), 1.25 × 104 cells (lane 4) of control cells, and 
1 × 105 cells of EZH2 KD cells (lane 5) were subjected western blotting with anti-EZH2 antibody. The original 
blot is presented in Supplementary Fig. 1. (c) The amounts of PRC2 complex components in EZH2 KD cells. 
Control or EZH2 KD cells were subjected to western blotting with anti-EZH2, anti-SUZ12, anti-EED, and 
anti-β -actin antibodies. The original blots are presented in Supplementary Fig. 2. (d) Production of infectious 
virions. At 60 h post transfection, control and EZH2 KD cells were infected with influenza virus at MOI of 0.3. 
The culture supernatants were collected at 24, 28, 32, and 36 h post infection, and subjected to plaque assays. 
The average titers and standard deviations determined from three independent experiments are shown. (e) 
Expression levels of vRNA and mRNA in EZH2 KD cells. Total RNAs prepared from control and EZH2 KD 
cells at 6 h post infection were subjected to the quantitative real-time PCR. The amounts of vRNA and mRNA 
of segment 5 in control cells were indicated as 100%, respectively. The average expression levels and standard 
deviations determined from three independent experiments are shown. (f) Expression levels of M1 and NS2 in 
control and EZH2 KD cells. At 6 h post infection, control and EZH2 KD cells were subjected to SDS-PAGE, and 
carried out western blotting with anti-EZH2, anti-M1, anti-NS2, and anti-β -actin antibodies. The original blots 
are presented in Supplementary Fig. 3.
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the mAb61A5 antibody recognizes NP on the viral genome28, and thus the interaction of M1 with vRNP can 
be detected by the in situ PLA system. The number of PLA signals between vRNP and M1 in EZH2 KD cells 
decreased to approximately 50% of that in control cells at 6 h post infection (Fig. 4a,b). These results suggest that 
PRC2 complex is involved in the interaction between M1 and vRNP.
PRC2 complex facilitates M1-vRNP complex formation through the direct interaction with M1. 
To examine the molecular mechanism of the assembly of M1-vRNP complex stimulated by PRC2 complex, we 
performed immunoprecipitation assays using recombinant PRC2 complex and M1. 3xFLAG-EZH2 and SUZ12 
were purified from 293T cells using anti-FLAG antibody-conjugated agarose (Fig. 4c, lanes 2 and 3, Supplementary 
Fig. 7). Other PRC2 subunits were also co-purified with 3xFLAG-EZH2 and 3xFLAG-SUZ12, respectively (Fig. 4d 
and Supplementary Fig. 8), which suggests that part of purified 3xFLAG-EZH2 and 3xFLAG-SUZ12 forms PRC2 
complexes. We found that M1 was co-immunoprecipitated with PRC2 complexes purified with 3xFLAG-EZH2 and 
3xFLAG-SUZ12, respectively (Fig. 4e, lanes 4–6 and Supplementary Fig. 9). Next, we tested the interaction of M1 
with vRNP in the presence or absence of PRC2 complex by immunoprecipitation assays with anti-NP antibody using 
purified recombinant proteins. The amount of M1 co-immunoprecipitated with vRNP was increased in the presence 
of PRC2 complex (Fig. 4f, lanes 4–6 and Supplementary Fig. 10). These findings suggest that PRC2 complex could 
recruit M1 onto vRNA for the nuclear export of vRNP through the direct interaction of PRC2 complex with M1.
Discussion
PRC2 complex has the methyltransferase activity of histone H3K27me3, which is one of the markers of fHC29. 
Recently, it was reported that CRM1 interacts with a particular focus of fHC, and recruits Nup98-HoxA9 and 
CALM-AF10 fusion proteins on fHC through the recognition of NES30,31. These findings suggest that NS2 could 
Figure 2. PRC2 complex is involved in the nuclear export of vRNP. (a,b) Intracellular localization of the 
viral genome in control and EZH2 KD cells. At 60 h post transfection of siRNA, control and EZH2 KD cells 
were infected with influenza virus at MOI of 5 (left panels). At 6 h post infection, FISH assays were carried 
out with an RNA probe complementary to segment 1 vRNA (green). Nuclei were counter-stained with DAPI 
(blue). The average number of the cells, in which more than 60% of vRNA shows nuclear localization pattern, 
was determined from three independent experiments (panel b; n > 100). To visualize endogenous NF-κ B, 
control and EZH2 KD cells were subjected to indirect immunofluorescence assays with anti-NF-κ B antibody 
(right panels). The level of significance was determined by Student’s t test. (c,d,e) HeLa cells were treated with 
either DMSO or 500 nM of GSK126 for 60 h. The cells were infected with influenza virus at MOI of 5. At 6 h 
post infection, cells were subjected to western blotting with anti-EZH2, anti-histone H3K27me3, anti-M1, 
and anti-β -actin antibodies (panel c). The original blots are presented in Supplementary Fig. 4. To examine 
the intracellular localization of vRNA, FISH assays were carried out with the RNA probe complementary to 
segment 1 vRNA (panel d, green). Nuclei were counter-stained with DAPI (blue). The average number of 
cells, in which more than 60% of vRNP shows the nuclear localization pattern, was determined from three 
independent experiments (panel e; n > 100). The level of significance was determined by Student’s t test. N. S., 
not significant (P > 0.05).
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be recruited to CRM1-bound fHC through the NES. NP also binds to histone H3K27me311, suggesting that vRNP 
localizes at fHC. Thus, it is possible that M1 is recruited to fHC through its interaction with PRC2 complex, and 
the export complex of vRNP is formed at fHC. CHD3, one of the deacetylase components of NuRD complex, also 
promotes the nuclear export of vRNP through its interaction with NS232. It has been reported that NuRD complex 
binds to histone H3K27me3 and cooperates with PRC2 to suppress cellular gene expression33–35. Taken together, 
these findings suggest that fHC functions as an assembly site for the export complex of vRNP.
Figure 3. Interaction of PRC2 complex with vRNP complex in infected cells. (a) Interaction of vRNP 
with PRC2 complex. At 6 h post infection, infected cells were subjected to immunoprecipitation assays 
with either non-specific IgG (lane 2) or anti-NP (lane 3) antibody-conjugated protein A Sepharose. Co-
immunoprecipitated proteins were separated by 10% of SDS-PAGE, and analyzed by western blotting with 
anti-EZH2, anti-EED, anti-SUZ12, and anti-NP antibodies. The original blots are presented in Supplementary 
Fig. 5. (b) Interaction of PRC2 complex with vRNA. At 6 h post infection, infected HeLa cells were subjected to 
immunoprecipitation assays with non-specific IgG, anti-EZH2, and anti-SUZ12 antibodies, respectively. The 
absolute amounts of precipitated RNAs were quantified by quantitative real-time PCR as descried in Methods. 
(c) Interaction of EZH2 with vRNP complex. HeLa cells were transfected with a plasmid expressing 3xFLAG-
EZH2, and then infected with influenza virus at MOI of 5. At 6 h post infection, these cells were subjected to 
immunoprecipitation assays with either non-specific IgG (lane 2) or anti-FLAG (lane3) antibody-conjugated 
Sepharose. Co-immunoprecipitated proteins were separated by 7.5% or 12.5% of SDS-PAGE, and analyzed by 
western blotting with anti-FLAG, anti-PB1, anti-PB2, anti-NP, anti-M1, and anti-NS2 antibodies. The original 
blots are presented in Supplementary Fig. 6.
www.nature.com/scientificreports/
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We demonstrated that EZH2 KD results in the accumulation of vRNP in the nucleus (Fig. 2a). Proteomics 
analyses revealed that a number of viral proteins are subjected to post-translational modifications for virus 
growth36. However, the treatment of GSK126 does not affect the localization of the viral genome (Fig. 2d). This 
suggests that the methyltransferase activity of PRC2 complex and histone H3K27me3 are not important for vRNP 
export. Previous reports showed that histone H3K27me3 is required for the assembly of heterochromatin, but not 
essential for the maintenance of the chromatin compaction3,37,38. Therefore, it is possible that the fHC region is 
important for the formation of vRNP export complex.
A number of different RNA and DNA viruses inhibit the formation of PML NB to prevent antiviral responses, 
and certain viruses hijack PML NB for their viral replication and transcription39,40. It is also reported that the 
proviral promoter of HIV is assembled at fHC near PML NB and that the promoter is activated in response to the 
disruption of PML NB41. Further, it is worthy to note that some parts of M1, NS2, and vRNA are found at PML 
NB20,42,43. Based on these reports, it is possible that PML NB is in close proximity to fHC, and that vRNP might 
Figure 4. PRC2 complex interacts with M1, and facilitates the interaction between M1 and vRNP. (a,b) in situ 
PLA assays. At 60 h post transfection of siRNA, control and EZH2 KD cells were infected with influenza virus at 
MOI of 5. At 6 h post infection, cells were subjected to in situ PLA assays with rabbit anti-M1 and mouse anti-NP 
antibodies (red), then indirect immunofluorescence assays were carried out to detect the intracellular localization 
of M1 (green). Nuclei were counter-stained with DAPI (blue). The number of PLA signals was obtained from 
three-dimensional reconstruction images by IMARIS software (n = 11). The level of significance was determined 
by Student’s t test. (c) Purification of recombinant proteins. Purified 3xFLAG-EZH2, 3xFLAG-SUZ12, and His-
M1 proteins were applied to 10% SDS-PAGE, and visualized by CBB staining. The original blot is presented in 
Supplementary Fig. 7. (d) Western blotting of purified proteins. Purified proteins were subjected to western 
blotting with anti-EZH2, anti-SUZ12, and anti-EED antibodies. The original blot is presented in Supplementary 
Fig. 8. (e) Interaction of PRC2 complex with M1. Recombinant His-M1 (12 pmol) was incubated without 
(lanes 1 and 4) or with either 8 pmol of 3xFLAG-EZH2 (lanes 2 and 5) or 8 pmol of 3xFLAG-SUZ12 (lanes 
3 and 6) for 1 h. Then, the proteins were subjected to immunoprecipitation assays with anti-FLAG antibody, 
followed by western blotting with anti-flag and anti-M1 antibodies (lanes 4–6). The original blots are presented 
in Supplementary Fig. 9. (f) PRC2 complex facilitates the interaction of M1 with vRNP. Recombinant His-M1 
(12 pmol) and vRNP purified from influenza virions were incubated without (lanes 1 and 4) or with either 
8 pmol of 3xFLAG-EZH2 (lanes 2 and 5) or 8 pmol of 3xFLAG-SUZ12 (lanes 3 and 6) for 1 h. Then, vRNP was 
immunoprecipitated with anti-NP antibody, and then the co-immunoprecipitated M1 was detected by western 
blotting with anti-M1 antibody (lanes 4–6). The original blots are presented in Supplementary Fig. 10.
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translocate from PML NB to fHC. To further understand the regulatory mechanism of vRNP nuclear export, the 
significance of the accumulation of vRNP and viral proteins at PML NB requires further analysis.
Methods
Biological materials. Rabbit polyclonal antibodies against M1, PB1, PB2 NP and CTCF were pre-
pared as previously described13,44–46. Rabbit polyclonal antibodies against EZH2 (Abcam), EED (Proteintech), 
SUZ12 (Proteintech), HDAC1 (Upstate), pol II (Santa Cruz), RAD21 (Abcam), and mouse monoclo-
nal antibody against Brg1 (Santa Cruz), and rat polyclonal antibody against HP1β (Abcam) were pur-
chased. Mouse monoclonal antibodies against NP (mAb61A5) and Topoisomerase II were a gift from Dr. F. 
Momose (Kitasato University)28 and Dr. A. Kikuchi (Nagoya University), respectively. vRNP was prepared 
from purified influenza virus (A/Puerto Rico/8/34) as previously described47. For the construction of the 
plasmids expressing 3xFLAG-EZH2 or 3xFLAG-SUZ12, cDNA was generated from total RNA extracted 
from HeLa cells using oligo dT primer (5′ -TTTTTTTTTTTTTTTTTTTT-3′ ), then amplified with following 
specific primer sets: 5′ -AGATCTACGCGTATGGGCCAGACTGGGAAGAAA-3′ and 5′ -AGATCTAC 
G C G T T C A AG G G AT T T C C AT T T C T C T T T C G - 3 ′   f or  E Z H 2 ;  5 ′  - C AG G A AT T C C T C G AG 
ATGGCGCCTCAGAAGCAC-3′ and 5′ -CAGGAATTCCTCGAGTCAGAGTTTTTGTTTTTTGCTCTGT-3′ 
for SUZ12. To construct a plasmid for the expression of 3xFLAG-tagged proteins, the fragment 5 ′ - GATCCGC
CGCCACCATGGACTACAAGGATGACGACGACAAGGACTACAAGGATGACGACGACAAGGACTACAA
GGATGACGACGACAAGCATATGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCGA-3′ was 
inserted to pCAGGS digested with EcoR I and filled with Klenow fragment. The amplified cDNAs of EZH2 and 
SUZ12 were cloned into pCAGGS-3xFLAG digested with EcoR I, respectively. HeLa cells (a kind gift from Dr. 
MA. Yamada, The University of Tokyo) and 293T cells (a kind gift from Dr. Y. Kawaoka, The University of Tokyo) 
were maintained in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS), and 
MDCK cells (a kind gift from Dr. P. Palese, Icahn School of Medicine at Mount Sinai) were cultured in minimal 
essential medium (MEM) containing 10% FBS. GSK126 was purchased from Xcessbio.
Immunoprecipitation. At 6 h post infection, cells were cross-linked with 0.5% of formaldehyde at room 
temperature for 10 min. Fixed cells were lysed by sonication in a lysis buffer containing 50 mM Tris-HCl 
(pH 7.9), 150 mM NaCl, and 0.1% Triton X-100. The lysates were centrifuged at 14,000x g, and the super-
natants were subjected to the immunoprecipitation assays with antibodies as indicated in figure legends. 
After washing with lysis buffer, co-immunoprecipitated proteins were eluted with 0.1 M glycine (pH 3.0). 
Co-immunoprecipitated proteins were separated by SDS-PAGE and analyzed by western blotting with antibodies 
as indicated in each figure legend.
Gene silencing mediated by siRNA. Cells (7 × 105) were transfected with 30 pmol of either control siRNA 
or siRNA against EZH2 (Invitrogen) using lipofectamine RNAi Max (Life Technologies) according to the man-
ufacture’s protocol.
Quantification of viral RNA. Total RNAs were purified from infected cells using RNA purification kit 
(Nacalai). For RNP immunoprecipitation assays, infected cells were cross-linked with 0.5% of formaldehyde 
for 10 min at room temperature. Fixed cells were lysed by sonication in a buffer containing 12.5 mM Tris-HCl 
(pH 7.9), 150 mM NaCl, 5 μ g/ml heparin, and 1% Triton X-100. The supernatants were recovered by centrifu-
gation at 14,000x g for 10 min, and subjected to immunoprecipitation assays. After sequential washes with high 
salt buffer containing 20 mM Tris-HCl (pH 7.9), 2 mM EDTA, 500 mM NaCl, and 1% Triton X-100, and LiCl 
buffer containing 10 mM Tris-HCl (pH 7.9), 1 mM EDTA, 250 mM LiCl, 1% deoxycholate, and 1% NP-40, viral 
RNAs co-immunoprecipitated with either EZH2 or SUZ12 from infected cells were subjected to the quantitative 
real-time PCR as previously described20. vRNA and cRNA of segment 5 synthesized by T7 RNA polymerase 
in vitro (Promega) were used as a standard for quantitative RT-RCR to quantify the absolute amount.
Indirect immunofluorescence assays and fluorescent in situ hybridization assays. Indirect 
immunofluorescence assays and fluorescent in situ hybridization assays were carried out as previously described20. 
Briefly, infected cells were fixed with 4% paraformaldehyde for 10 min at room temperature, permeabilized with 
PBS containing 0.5% Triton X-100 for 5 min at room temperature, and incubated with PBS containing 1% bovine 
serum albumin (BSA) for 1 h. Cells were incubated with primary antibodies as indicated in each figure legend 
for 1 h, and then incubated with Alexa Fluor488-conjugated secondary antibodies, respectively (Thermo Fisher 
Scientific). FISH assays were carried out using an RNA probe complementary to the segment 1 vRNA. Images 
were acquired as confocal sections taken at the same level of focus among samples.
In situ proximity ligation assays (PLA). In situ PLA was carried out as previously described48. Infected 
cells were fixed with 4% PFA for 10 min, followed by permeabilization with PBS containing 0.5% Triton X-100 
at room temperature for 5 min. The cells were incubated with PBS containing 1% skim milk for 30 min, and 
incubated with rabbit anti-M1 and mouse anti-NP antibodies for 1 h. PLA assays were performed using Duolink 
in situ PLA kit (Olink Bioscience) according to the manufacturer’s protocol. Counting of the PLA foci was carried 
out using IMARIS software (Carl Zeiss).
Purification of recombinant proteins. Purification of His-M1 was performed as previously described49. 
To purify the PRC2 complex, 293T cells were transfected with plasmids expressing either 3xFLAG-EZH2 or 
3xFLAG-SUZ12, and then incubated for 48 h. Transfected cells were lysed by sonication in a buffer contain-
ing 20 mM Tris-HCl (pH 7.9), 100 mM NaCl, and 0.1% Triton X-100. Lysates were incubated with FLAG 
antibody-conjugated agarose (Sigma) at 4 °C for 1 h. After washing with a buffer (Wash buffer) containing 50 mM 
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Tris-HCl (pH 7.9) and 175 mM KCl, 0.2 mM EDTA, 0.1% Triton X-100, and 10% glycerol, PRC2 complex was 
eluted with Wash buffer containing 0.5 mg/ml 3xFLAG peptide.
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